EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Progress of small molecules for targeted protein degradation: PROTACs and other technologies

Hong-Yi Zhao iD, Minhang Xin iD, San-Qi Zhang

Drug Development Research · 2023-04 · 84 (2) · 337-394

DOI: 10.1002/ddr.22026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 06.01.2023. Verfasst von Hong-Yi Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Proteolysis Targeting Chimera, Receptors, Estrogen. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 379 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent years have witnessed the rapid development of targeted protein degradation (TPD), especially proteolysis targeting chimeras. These degraders have manifested many advantages over small molecule inhibitors. To date, a huge number of degraders have been excavated against over 70 disease‐related targets. In particular, degraders against estrogen receptor and androgen receptor have crowded into phase II clinical trial. TPD technologies largely expand the scope of druggable targets, and provide powerful tools for addressing intractable problems that can not be tackled by traditional small molecule inhibitors. In this review, we mainly focus on the structures and biological activities of small molecule degraders as well as the elucidation of mechanisms of emerging TPD technologies. We also propose the challenges that exist in the TPD field at present.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteolysis Targeting ChimeraReceptors, EstrogenProteolysis

Stichwörter der Autor:innen

biological activitydegradersmechanismstructuretargeted protein degradation

Substanzen

Proteolysis Targeting ChimeraReceptors, Estrogen

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.

ORCID-Profile: Hong-Yi Zhao, Minhang Xin

Zitieren

APA

Zhao, H. Y., Xin, M., & Zhang, S. Q. (2023). Progress of small molecules for targeted protein degradation: PROTACs and other technologies. Drug Development Research, 84(2), 337-394. https://doi.org/10.1002/ddr.22026

Vancouver

Zhao HY, Xin M, Zhang SQ. Progress of small molecules for targeted protein degradation: PROTACs and other technologies. Drug Development Research. 2023;84(2):337-394. doi:10.1002/ddr.22026

BibTeX
@article{Zhao2023,
  author = {Zhao, Hong-Yi and Xin, Minhang and Zhang, San-Qi},
  title = {Progress of small molecules for targeted protein degradation: PROTACs and other technologies},
  journal = {Drug Development Research},
  year = {2023},
  volume = {84},
  number = {2},
  pages = {337--394},
  doi = {10.1002/ddr.22026}
}
Kostenlos starten →